The Technical Analyst
Select Language :
Kinnate Biopharma Inc. [KNTE]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Kinnate Biopharma Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Kinnate Biopharma Inc. is listed at the  Exchange

0.00% $2.66

America/New_York / 28 mar 2024 @ 16:00


Kinnate Biopharma Inc.: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 125.46 mill
EPS: -2.78
P/E: -0.960
Earnings Date: Mar 27, 2024
SharesOutstanding: 47.17 mill
Avg Daily Volume: 0.369 mill
RATING 2024-03-28
B-
Sell
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Sell
DE: Sell
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.960 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.16x
Company: PE -0.960 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.569
(-78.60%) $-2.09
Date: 2024-03-29
Expected Trading Range (DAY)

$ 2.58 - 2.74

( +/- 3.12%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-01 Krishnamohan Neha Sell 1 506 Common Stock
2024-03-01 Meltz Mark A Sell 558 Common Stock
2024-03-01 Williams Richard Thomas Sell 558 Common Stock
2023-12-01 Williams Richard Thomas Sell 541 Common Stock
2023-12-01 Krishnamohan Neha Sell 1 459 Common Stock
INSIDER POWER
99.73
Last 96 transactions
Buy: 16 586 943 | Sell: 15 783

Forecast: 16:00 - $2.65

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $2.65
Forecast 2: 16:00 - $2.65
Forecast 3: 16:00 - $2.65
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $2.66 (0.00% )
Volume 0.189 mill
Avg. Vol. 0.369 mill
% of Avg. Vol 51.19 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Kinnate Biopharma Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Kinnate Biopharma Inc.

RSI

Intraday RSI14 chart for Kinnate Biopharma Inc.

Last 10 Buy & Sell Signals For KNTE

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$2.33N/AActive
Profile picture for
            Kinnate Biopharma Inc.

KNTE

Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; KIN-3248 small-molecule kinase inhibitors that target cancer-associated alterations in fibroblast growth factor receptors FGFR2 and FGFR3 genes; and small molecule research programs, including Cyclin-Dependent Kinase 12(CDK12) inhibitor in its KIN004 program. The company was incorporated in 2018 and is headquartered in San Francisco, California. Kinnate Biopharma Inc. is a former subsidiary of Fount Therapeutics, LLC.

Last 10 Buy Signals

Date Signal @
TONUSDMar 29 - 11:185.05
GTUSDMar 29 - 11:19$10.24
KDAUSDMar 29 - 11:18$1.441
CHZUSDMar 29 - 11:20$0.148
1INCHUSDMar 29 - 11:200.598
SOLUSDMar 29 - 11:20$187.14
AGIUSDMar 29 - 11:190.435
PERPUSDMar 29 - 11:181.458
AVAXUSDMar 29 - 11:18$53.53
ADAUSDMar 29 - 11:18$0.659

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.